Pre-exposure prophylaxis for HIV: who will benefit and what are the challenges?

Am J Prev Med. 2013 Jan;44(1 Suppl 2):S163-6. doi: 10.1016/j.amepre.2012.10.005.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives*
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • HIV Infections / prevention & control*
  • Health Plan Implementation*
  • Humans
  • Organophosphorus Compounds / administration & dosage*
  • Primary Prevention

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
  • Organophosphorus Compounds
  • Deoxycytidine